ISPE GAMP5 Second Edition "What's New?"?
GAMP? is a registered trademark of ISPE, for more info and to purchase this document, please visit; https://ispe.org/publications/guidance-documents/gamp-5-guide-2nd-edition

ISPE GAMP5 Second Edition "What's New?"

ISPE recently published the second edition of?GAMP? 5: A Risk-Based Approach to Compliant GxP Computerized Systems, which has been the industry norm for over decades. Let's take a close look at this guide and see what is new.

The International Society of Pharmaceutical Engineers (ISPE) has published the second edition of GAMP?5; Good Automated Manufacturing Practices this August 2022.

According to International Task Force, a special ISPE SME group, the rationale for GAMP5 Second Edition was “aimed at protecting patient safety, product quality, and data integrity by facilitating and encouraging the achievement of computerized systems that are effective, reliable, and of high quality.”

GAMP provides practical guidance that facilitates the interpretation of regulatory requirements, establishes a common language and terminology, promotes a system life cycle approach based on good practice, and clarifies roles and responsibilities. It is not a prescriptive method or a standard, but rather provides pragmatic guidance, techniques, and tools for the practitioner. This guide offers a robust, cost-effective system when applied with expertise and good judgment.

ISPE GAMP5 Guideline comprises a main body and a set of supporting appendices. The main body provides principles and a life cycle framework applicable to GxP-regulated computerized systems. Practical guidance on a wide range of topics is provided in the supporting appendices.

No alt text provided for this image
Source : Figure 1.2 , ISPE GAMP5 (2nd Edition) Copyright ISPE 2022. All rights reserved. www.ispe.org

Apart from the main body of the GAMP5, there are appendices to enhance the subject and for a better explanation with examples, documents, and references. There are five main appendices, including:

  • Management Appendices (M)
  • Development Appendices (D)
  • Operation Appendices (O)
  • Special Interest Topics Appendices (S)
  • General Appendices (G)

New and Revised Materials in ISPE GAMP 5 Second Edition

There are new appendices including “Agile (D8), Software Tools (D9), Distributed Ledger Systems known as “Blockchain Technologies” (D10), IT Infrastructure (M11), and Critical Thinking (M12)”. Appendices such as “Specifying Requirements” (D1) and “Electronic Production Records” (S2) have been updated significantly while some other appendices were removed (Appendix D2 – Functional Specifications, O7 – Repair Activity and S5 – Managing Quality within an Outsourced IS/IT Environment) as a result of these new additions and the revisions.

As per the Task Force definition: “The overall GAMP 5 framework, key concepts, system life cycle, specification, and verification approach, and Quality Risk Management (QRM) process (aligned with ICH Q9 [14]) remains unchanged.”


A Synergy with the ISPE Initiatives

Over the next couple of years, there are important topic areas that have been developed and maintained by the ISPE such as “Knowledge Management”, “Advancing Pharmaceutical Quality”, and “Pharma 4.0”. Thanks to the new appendices and revised main body, the new edition of the GAMP5 is now synchronized and synergized with this topic area. With the ISPE definitions, a short description of these topic areas will help us better understand the second Edition of the GAMP5.

Knowledge Management

Firstly, focusing on how organizations create, manage, and use knowledge throughout the life cycle of a product, enables organizations to better manage their knowledge as a key asset, in turn improving the effectiveness of the pharmaceutical quality system, and providing operational benefits.

Advancing Pharmaceutical Quality

Secondly, building industry-for-industry tools and programs to help companies assess and improve their quality operations.

Pharma 4.0??

Thirdly, providing guidance, aligned with the regulatory requirements specific to the pharmaceutical industry, to accelerate Pharma 4.0 transformations. Also known as the Smart Factory, the objective of Pharma 4.0 is to enable organizations involved in the product life cycle to leverage the full potential of digitalization to provide faster innovations for the benefit of patients.

No alt text provided for this image
Source : Figure 1.1 , ISPE GAMP5 (2nd Edition) Copyright ISPE 2022. All rights reserved. www.ispe.org

Key Concept of the ISPE GAMP5 Second Edition

There are five key concepts in the ISPE GAMP5 that are applied through the process:

  1. Product and process understanding
  2. Life cycle approach within a QMS
  3. Scalable life cycle activities
  4. Science-based QRM
  5. Leveraging supplier involvement

No alt text provided for this image
Source : Figure 2.1 , Key Concepts of this Guide, ISPE GAMP5 (2nd Edition) Copyright ISPE 2022. All rights reserved. www.ispe.org

Without a proper understanding of the process, any application, including the GAMP5 environment will not be possible. Thus, the multi-disciplinary involvement of different departments such as engineering, production, planning, quality, etc., is critical to make science and risk-based decisions. Another critical point here is to understand that the process is a never-ending cycle unless you decide to retire, destruct or mitigate the system. For that reason, the life cycle approach is critical. There should be periodic reviews of the plans to ensure that the changes in this living system are defined and well-addressed. In most cases, the supplier has the most critical information that should be transferred or exchanged with the stakeholders. Leveraging this supplier involvement will allow you to get a better understanding, and easy to adopt and integrate systems and maintain them seamlessly thanks to this know-how from the supplier.

Iterative and Incremental Approach

As part of this “life-cycle approach”, the second edition is now covering the “Iterative and Incremental Approach” for achieving compliance and fitness for the intended use. The classic linear approach was suggesting a one-way development, starting with planning and specification to the verification and reporting as a final step after successful configuration and/or coding.

No alt text provided for this image
Source : Figure 3.3 , Linear Approach, ISPE GAMP5 (2nd Edition) Copyright ISPE 2022. All rights reserved. www.ispe.org

The new iterative and incremental approach has a life-cycle structure that will allow us to review, update and re-visit steps to achieve compliance and fitness for the intended use.

No alt text provided for this image
Source : Figure 3.4 , Iterative and Incremental Approach, ISPE GAMP5 (2nd Edition) Copyright ISPE 2022. All rights reserved. www.ispe.org


Maybe critical thinking is the most important change in this second edition.

We have been using the “risk-based approach” for a while, however, over-thinking or over-estimating due to an excessive amount of “risk assumption” sometimes put us in a worst situation than where we initially started. Of course, we will continue implementing the risk-based approach however, as shown in the image, we will focus on "optimal benefit" thanks to the critical thinking approach.

No alt text provided for this image
Source : Figure 3.5 , Critical Thinking for Computerized Systems, ISPE GAMP5 (2nd Edition) Copyright ISPE 2022. All rights reserved. www.ispe.org

How to get this ISPE GAMP5 2nd Edition??

ISPE GAMP5 Second Edition can be found on the ispe.org website, under “Publications, Guide Documents”. Currently, only digital copies can be purchased, with hardcopy sets to be available from the same ISPE portal soon. For more information, please visit ispe.org

要查看或添加评论,请登录

Ha?im Solmaz的更多文章

  • What is NOT Cleanroom Monitoring?

    What is NOT Cleanroom Monitoring?

    Contamination Control is the Key On 15 October 2024, the Journal of Pharmaceutical and Biomedical Analysis published an…

    5 条评论
  • Will we see the new revision of ISO14644-3 Soon?

    Will we see the new revision of ISO14644-3 Soon?

    In this edition, we delve into ISO 14644-3:2019, the pivotal standard governing cleanroom test methods, and explore the…

    4 条评论
  • Testing HEPA Filters. Why & How?

    Testing HEPA Filters. Why & How?

    We have two different HEPA filter tests; efficiency test & integrity test. Both tests aim to verify the performance of…

    8 条评论
  • ISO/TR "Airborne Sampling Techniques" is one year old!

    ISO/TR "Airborne Sampling Techniques" is one year old!

    Technical Report ISO/TR14644-21 "Airborne Particle Sampling Techniques" has been out for almost a year now. We are…

    2 条评论
  • What is "Source Strength"?

    What is "Source Strength"?

    New ISO 14644-4 Cleanrooms and associated controlled environments, Part 4 "Design, construction and start-up" was…

    3 条评论
  • 3 easy Steps for Cleanroom Classification

    3 easy Steps for Cleanroom Classification

    ISO14644-1:2015 defines cleanroom classification basics. There are 45+ pages in this document, including annexes to…

    1 条评论
  • How to Perform Proper Air Visualization Study?

    How to Perform Proper Air Visualization Study?

    Air visualization test, even mentioned under "supportive tests" in ISO 14644-3:2019 Cleanroom Test Methods standard, is…

    2 条评论
  • Hazard Analysis and Critical Control Points "HACCP"

    Hazard Analysis and Critical Control Points "HACCP"

    In one of our previous newsletter editions, we talked about risk assessment. In this edition, we will see how we can…

  • FDA Perspective on Data Integrity and cGMP Compliance

    FDA Perspective on Data Integrity and cGMP Compliance

    The U.S.

    1 条评论
  • "What do you think?"

    "What do you think?"

    Great question indeed! "Nothing, for now, give me more details" or "I have an idea, let me tell you!". Sometimes this…

社区洞察

其他会员也浏览了